COMBINED THERAPY BY USING ANTIANGIOGENIC AGENTS AND TNF-ALPHA Russian patent published in 2008 - IPC A61K38/19 A61K38/21 A61P35/00 

Abstract RU 2316337 C2

FIELD: medicine, combined therapy.

SUBSTANCE: invention relates to pharmaceutical composition for endothelial tumor treatment containing in therapeutically effective amount antiangiogenic agent such as polypeptide including RGD sequence namely cyclo(Arg-Gly-Asp-Dphe-NmeVal) and tumor necrosis factor TNFα. Also disclosed are kit containing pharmaceutical composition, application of abovementioned pharmaceutical composition and kit, and method for therapy.

EFFECT: agent for effective treatment of endothelial tumors.

15 cl, 16 ex, 8 dwg

Similar patents RU2316337C2

Title Year Author Number
COMBINED THERAPY USING INHIBITORS OF TYROSINE KINASE RECEPTORS AND INHIBITORS OF ANGIOGENESIS 2001
  • Gudman Sajmon
  • Krejsh Khans-Georg
RU2292904C2
PHARMACEUTICAL COMPOSITIONS AIMED AT Erb-B1 RECEPTORS 2003
  • Krejsh Khans-Georg
  • Shmidt Jurgen
RU2354402C2
METHOD FOR INHIBITING CEREBRAL TUMORS GROWTH DUE TO SELECTED ANTAGONISTS OF INTEGRINS 2000
  • Log Uolter E.
RU2255765C2
METHOD FOR RECEPTOR TYROSINE KINASE INHIBITION WITH USE EXTRACELLULAR ANTAGONIST AND INTRACELLULAR ANTAGONIST 2004
  • Vaksal Samuehl'
RU2431500C2
METHODS AND COMPOSITION USEFUL FOR ANGIOGENESIS INHIBITION 1995
  • Piter Bruks
  • Dehvid A. Cheresh
RU2162712C2
INTEGRIN RECEPTOR ANTAGONISTS AND USE THEREOF 2012
  • Mackel Michael John
  • Park John Y.
  • Karageozian Hampar L.
  • Karageozian Vicken H.
RU2721907C2
COMBINED THERAPY WITH USING ALPHA5BETA1 ANTAGONISTS 2007
  • Chuntkharapaj Anan
  • Plauman Greg
  • Tess'E-Lavin' Mark
  • U Jan'
  • E Vehjlan'
RU2465282C2
RECOVERED HUMAN ANTIBODY OR ITS ANTIGEN-BINDING FRAGMENT (VERSIONS), METHOD OF TREATING hTNFα-MEDIATED DISEASES WITH MEDIATION THEREOF (VERSIONS), PHARMACEUTICAL COMPOSITION, RECOMBINANT HUMAN ANTIBODY OR ITS ANTIGEN-BINDING FRAGMENT, RECOVERED NUCLEIC ACID (VERSIONS) 2005
  • Allen Debora Dzh.
  • Vogen Tristan Dzh.
  • Kajmaksalan Zera
  • Labkovski Boris
  • Makginess Brajen T.
  • Mankovich Dzhon Eh.
  • Roberts Ehndrju Dzh.
  • Sakorafash Pol'
  • Sehlfeld Dzhokhen G.
  • Uajt Majkl
  • Uilton Ehlison Dzh.
  • Khugenbum Khendrikus R. Dzh. M.
  • Shoehnkhaut Dehvid
RU2458704C9
BISPECIFIC BINDING AGENTS FOR MODULATING BIOLOGICAL ACTIVITY 2005
  • Nilsen Ulrik B.
  • Shoehberl' Birgit M.
RU2433831C2
METHODS AND COMPOSITIONS USED FOR INHIBITING ANGIOGENESIS 1997
  • Bruks Piter
  • Cheresh Dehvid A.
  • Silletti Stiven
RU2194528C2

RU 2 316 337 C2

Authors

Grell' Mattias

Gudman Sajmon

Rjugg Kurtsio

Dates

2008-02-10Published

2002-04-18Filed